Nurix Therapeutics, Inc.
NRIX
42 insider filings · Latest: Oct 15, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Feb 9, 2026 | Feb 10 12:47 AM | Christine RingChief Legal Officer | Sale | 14,261 | $16.66 | $237.6K | 42,749(D) | View → |
| Feb 9, 2026 | Feb 9 9:29 PM | CHRISTINE RING | Proposed Sale | 14,261 | $16.85 | $240.3K | — | View → |
| Jan 30, 2026 | Jan 31 1:39 AM | Houte Hans VanChief Financial Officer | Sale | 3,661 | $16.60 | $60.8K | 45,427(D) | View → |
| Jan 30, 2026 | Jan 31 1:38 AM | Christine RingChief Legal Officer | Sale | 4,421 | $16.60 | $73.4K | 57,010(D) | View → |
| Jan 30, 2026 | Jan 31 1:36 AM | Gwenn HansenChief Scientific Officer | Sale | 4,895 | $16.60 | $81.2K | 83,672(D) | View → |
| Jan 20, 2026 | Jan 21 12:57 AM | Christine RingChief Legal Officer | Sale | 3,760 | $18.42 | $69.3K | 50,897(D) | View → |
| Dec 18, 2025 | Dec 18 9:21 PM | CHRISTINE RING | Proposed Sale | 7,520 | $18.21 | $136.9K | — | View → |
| Nov 24, 2025 | Nov 24 9:27 PM | CHRISTINE RING | Proposed Sale | 37,600 | $16.76 | $630.2K | — | View → |
| Nov 3, 2025 | Nov 3 9:27 PM | JOHANNES VAN HOUTE | Proposed Sale | 6,284 | $12.94 | $81.3K | — | View → |
| May 2, 2025 | May 2 8:22 PM | JOHANNES VAN HOUTE | Proposed Sale | 6,198 | $11.16 | $69.2K | — | View → |
| Mar 3, 2025 | Mar 3 9:17 PM | JOHANNES VAN HOUTE | Proposed Sale | 5,825 | $15.45 | $90.0K | — | View → |
| Jan 31, 2025 | Jan 31 9:33 PM | CHRISTINE RING | Proposed Sale | 5,760 | $20.02 | $115.3K | — | View → |
| Jan 2, 2025 | Jan 2 9:20 PM | CHRISTINE RING | Proposed Sale | 5,760 | $18.84 | $108.5K | — | View → |
| Dec 2, 2024 | Dec 2 9:36 PM | CHRISTINE RING | Proposed Sale | 5,760 | $22.11 | $127.4K | — | View → |
| Nov 4, 2024 | Nov 4 9:29 PM | CHRISTINE RING | Proposed Sale | 3,290 | $24.47 | $80.5K | — | View → |
| Nov 1, 2024 | Nov 1 8:50 PM | JOHANNES VAN HOUTE | Proposed Sale | 3,546 | $24.58 | $87.2K | — | View → |
| Nov 1, 2024 | Nov 1 8:41 PM | CHRISTINE RING | Proposed Sale | 5,760 | $24.58 | $141.6K | — | View → |
| Oct 1, 2024 | Oct 1 8:32 PM | CHRISTINE RING | Proposed Sale | 9,050 | $22.47 | $203.4K | — | View → |
| Sep 3, 2024 | Sep 3 8:28 PM | CHRISTINE RING | Proposed Sale | 9,050 | $25.20 | $228.1K | — | View → |
| Aug 26, 2024 | Aug 26 8:25 PM | JOHANNES VAN HOUTE | Proposed Sale | 20,000 | $24.02 | $480.4K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 15, 2026 | May 15 9:37 PM | Julia P GregoryDirector | Grant/Award | 31,250 | $15.86 | 31,250(D) | View → |
| Apr 30, 2026 | Apr 30 9:38 PM | Houte Hans VanChief Financial Officer | Option Exercise | 8,608 | — | 22,867(D) | View → |
| Apr 30, 2026 | Apr 30 9:37 PM | Christine RingChief Legal Officer | Option Exercise | 8,608 | — | 22,867(D) | View → |
| Apr 30, 2026 | Apr 30 9:35 PM | Gwenn HansenChief Scientific Officer | Option Exercise | 8,608 | — | 22,867(D) | View → |
| Feb 10, 2026 | Feb 10 11:09 PM | Houte Hans VanChief Financial Officer | Grant/Award | 136,625 | $16.45 | 42,875(D) | View → |
| Feb 10, 2026 | Feb 10 10:55 PM | Christine RingChief Legal Officer | Grant/Award | 136,625 | $16.45 | 42,875(D) | View → |
| Feb 10, 2026 | Feb 10 10:50 PM | Gwenn HansenChief Scientific Officer | Grant/Award | 136,625 | $16.45 | 42,875(D) | View → |
| Feb 10, 2026 | Feb 10 10:43 PM | SANDS ARTHUR TDirector, President, CEO | Grant/Award | 562,500 | $16.45 | 562,500(D) | View → |
| Feb 3, 2026 | Feb 4 2:12 AM | Gwenn HansenChief Scientific Officer | Option Exercise | 31,333 | $0.84 | 0(D) | View → |
| Jan 30, 2026 | Jan 31 1:39 AM | Houte Hans VanChief Financial Officer | Option Exercise | 11,496 | — | 25,725(D) | View → |
| Jan 30, 2026 | Jan 31 1:38 AM | Christine RingChief Legal Officer | Option Exercise | 10,534 | — | 25,725(D) | View → |
| Jan 30, 2026 | Jan 31 1:36 AM | Gwenn HansenChief Scientific Officer | Option Exercise | 11,816 | — | 25,725(D) | View → |
| Jan 20, 2026 | Jan 21 12:57 AM | Christine RingChief Legal Officer | Option Exercise | 3,760 | $1.86 | 8,643(D) | View → |
← Previous
Page 2 of 2